FRACASSI, Elena
 Distribuzione geografica
Continente #
NA - Nord America 2.387
EU - Europa 2.150
AS - Asia 1.604
SA - Sud America 257
AF - Africa 32
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.437
Nazione #
US - Stati Uniti d'America 2.343
GB - Regno Unito 847
SG - Singapore 639
CN - Cina 552
IT - Italia 231
BR - Brasile 220
SE - Svezia 206
HK - Hong Kong 167
DE - Germania 164
RU - Federazione Russa 159
FR - Francia 144
FI - Finlandia 140
IE - Irlanda 139
TR - Turchia 58
JP - Giappone 37
UA - Ucraina 35
KR - Corea 31
VN - Vietnam 27
IN - India 24
CA - Canada 23
AT - Austria 17
BE - Belgio 15
AR - Argentina 12
NL - Olanda 12
BD - Bangladesh 11
NP - Nepal 11
IQ - Iraq 10
MX - Messico 10
EC - Ecuador 9
ES - Italia 9
ID - Indonesia 8
ZA - Sudafrica 8
EG - Egitto 7
CZ - Repubblica Ceca 6
IR - Iran 6
TG - Togo 6
AU - Australia 5
CH - Svizzera 5
SA - Arabia Saudita 4
VE - Venezuela 4
BG - Bulgaria 3
CL - Cile 3
GR - Grecia 3
JM - Giamaica 3
LT - Lituania 3
PE - Perù 3
PK - Pakistan 3
PL - Polonia 3
UZ - Uzbekistan 3
AL - Albania 2
BO - Bolivia 2
BW - Botswana 2
CO - Colombia 2
KW - Kuwait 2
LB - Libano 2
PY - Paraguay 2
SV - El Salvador 2
TN - Tunisia 2
TW - Taiwan 2
AM - Armenia 1
AZ - Azerbaigian 1
BS - Bahamas 1
CD - Congo 1
CM - Camerun 1
CR - Costa Rica 1
DM - Dominica 1
DZ - Algeria 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
LC - Santa Lucia 1
MA - Marocco 1
ML - Mali 1
PF - Polinesia Francese 1
PH - Filippine 1
PT - Portogallo 1
RO - Romania 1
SI - Slovenia 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 6.437
Città #
Southend 767
Chandler 329
Singapore 302
Dallas 293
Jacksonville 287
Ann Arbor 174
Hong Kong 165
Ashburn 148
Dublin 139
Woodbridge 132
Beijing 107
Houston 96
New York 56
Lawrence 54
Princeton 54
Wilmington 53
Verona 50
Jinan 49
Munich 39
Nanjing 37
Milan 36
Shenyang 36
Los Angeles 35
Tokyo 33
Helsinki 30
Redmond 30
Turku 23
São Paulo 22
Columbus 19
The Dalles 19
Zhengzhou 19
Ningbo 18
Tianjin 18
Haikou 17
Hebei 17
Changsha 16
Brussels 15
Sindelfingen 15
Boardman 14
Fuzhou 14
Taizhou 14
Moscow 13
Taiyuan 13
Buffalo 12
Jiaxing 12
Redwood City 12
Brooklyn 11
Nanchang 11
Santa Clara 11
Kathmandu 10
Redondo Beach 10
Seattle 10
Washington 10
Boston 9
Düsseldorf 9
Hangzhou 9
Lancaster 9
Orani 9
Guangzhou 8
Jakarta 8
London 8
Vienna 8
Amsterdam 7
Atlanta 7
Ho Chi Minh City 7
Norwalk 7
Rio de Janeiro 7
Sanayi 7
Ankara 6
Baghdad 6
Cagliari 6
Charlotte 6
Detroit 6
Dongguan 6
Lanzhou 6
Lappeenranta 6
Lomé 6
Montreal 6
San Francisco 6
Council Bluffs 5
Esslingen am Neckar 5
Hanoi 5
Hyderabad 5
Izmir 5
Turin 5
Belo Horizonte 4
Brasília 4
Brescia 4
Chennai 4
Chicago 4
Coventry 4
Córdoba 4
Falls Church 4
Frankfurt am Main 4
Johannesburg 4
Mexico City 4
Nuremberg 4
Palermo 4
Porto Alegre 4
Seoul 4
Totale 4.201
Nome #
Artrite Reumatoide e Metabolismo Minerale 198
Long-term effects of amino-bisphosphonates on circulating gamma-delta T cells 168
25-hydroxyvitamin D levels in healthy premenopausal wome: association with bone turnover markers and bone mineral density 161
Bone mineral density and bone turnover in premenopausal women with rheumatoid arthritis 152
Prednisone compared to methysprednisolone in the polymyalgia rheumatica treatment 140
AB0776 18F-Fluoride PET/CT for Detection of Axial Involvement in Ankylosing Spondylitis: 139
Bisphosphonate treatment of postmenopausal osteoporosis is associated with a dose dependent increase in serum sclerostin. 137
Teriparatide Treatment in Adult Patients with Osteogenesis Imperfecta Type I. 135
Serum Levels of Tryptase Suggest That Mast Cells Might Have an Antiinflammatory Role in Rheumatoid Arthritis: Comment on the Article by Rivellese et al 135
Bisphosphonates vs infliximab in ankylosing spondylitis treatment. 131
Effects of intra-articular clodronate in the treatment of knee osteoarthritis: results of a double-blind, randomized placebo-controlled trial 130
Sclerostin and DKK1 in postmenopausal osteoporosis treated with Denosumab. 122
Prevalence of osteoporosis in patients affected by mastocytosis 120
Higher Level of Dickkopf-1 is Associated with Low Bone Mineral Density and Higher Prevalence of Vertebral Fractures in Patients with Ankylosing Spondylitis 120
Dose-dependent short-term effects of single high doses of oral vitamin D3 on bone turnover markers 119
Osteopetrosi 117
Gender differences in clinical features and quality of life of patients with axial spondyloarthritis and psoriatic arthritis 117
Distinct effect of zoledronate and clodronate on circulating levels of DKK1 and sclerostin in women with postmenopausal osteoporosis. 116
Sclerostin and DKK1 in primary hyperparathyroidism. 114
Calcio e derivati della vitamina D, terapia sostitutiva, calcitonina, fluoruri, bisfosfonati 110
Artropatie degenerative 109
Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women. 107
Prevalence and Factors Associated with Subclinical Left Ventricular Systolic Dysfunction Evaluated by Mid-Wall Mechanics in Rheumatoid Arthritis 105
Coping strategies, emotional distress and perceived disease severity in a cohort of patients with rheumatoid arthritis: a mediation analysis 104
Vitamina D e artrite reumatoide 104
Short-term effects on bone turnover markers of a single high dose of oral vitamin D₃. 104
Osteoporosi 103
Focal bone involvement in inflammatory arthritis: the role of IL17 103
Titer-Dependent Effect of Anti-Citrullinated Protein Antibodies On Systemic Bone Mass in Rheumatoid Arthritis Patients 103
Previous use of amino-bisphosphonates and circulating gamma/delta T cells 102
Vitamin D and rheumatic diseases. 102
Long-term consequences of a treatment course with bisphosphonates in primary hyperparathyroidism 101
Long-term effects of neridronate and its discontinuation in patients with primary hyperparathyroidism 97
Depression is associated with increased disease activity and higher disability in a large Italian cohort of patients with rheumatoid arthritis 96
Invecchiamento dell'apparato scheletrico 95
Osteoporosis Treatment: When to Discontinue and When to Re-start 94
Development and First Validation of a Disease Activity Score for Gout 93
Neridronic acid for the treatment of bone metabolic diseases 92
Disease Activity and Anticitrullinated Peptide Antibody Positivity Predict the Worsening of Ventricular Function in Rheumatoid Arthritis 92
Marked increases in bone mineral density and biochemical markers of bone turnover in patients with anorexia nervosa gaining weight 89
The waning of teriparatide effect on bone formation markers in postmenopausal osteoporosis is associated with increasing serum levels of DKK1 89
In patients with rheumatoid arthritis, Dickkopf-1 serum levels are correlated with parathyroid hormone, bone erosions and bone mineral density 89
Vitamin D and fractures: a systematic review 86
Chronic intravenous aminobisphosphonate therapy increases high-density lipoprotein cholesterol and decreases low-density lipoprotein cholesterol 83
Association between long-term exposure to air pollution and immune-mediated diseases: a population-based cohort study 83
Rational and results of weekly treatment with calcidiol in postmenopausal and senile osteoporosis 81
Environmental Air Pollution Is a Predictor of Poor Response to Biological Drugs in Chronic Inflammatory Arthritides 81
Permanent Discontinuation of Glucocorticoids in Polymyalgia Rheumatica is Uncommon but May Be Enhanced by Amino Bisphosphonates 78
The volumetric bone density and cortical thickness in adult patients affected by osteogenesis imperfecta. 71
Risk factors for hip fracture in elderly persons 71
Association between exposure to fine particulate matter and osteoporosis: a population-based cohort study 71
Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis? 68
Profile of bazedoxifene/conjugated estrogens for the treatment of estrogen deficiency symptoms and osteoporosis in women at risk of fracture. 67
Rational and results of weekly treatment with calcidiol in postmenopausal and senile osteoporosis,Razionale e risultati del trattamento settimanale con calcifediolo nell'osteoporosi postmenopausale e senile 67
Risk factors for hip fracture in elderly persons 66
Real-life short-term effectiveness of anti-osteoporotic treatments: a longitudinal cohort study 64
Usefulness of CHA2 DS2 -VASc score to predict mortality and hospitalization in patients with inflammatory arthritis 63
Comparison and potential determinants of health-related quality of life among rheumatoid arthritis, psoriatic arthritis, and spondyloarthritis: A cross-sectional study 63
Clinical and psychological characteristics associated with negative beliefs and concerns about treatment necessity in rheumatic diseases 61
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life data 59
Depression as a possible determinant of fatigue in patients with axial spondyloarthritis 56
Treatment with secukinumab in multi-comorbid patients with psoriatic arthritis 54
Changes in bone turnover markers and bone modulators during abatacept treatment 53
Pharmacodynamics of Oral Cholecalciferol in Healthy Individuals with Vitamin D Deficiency: A Randomized Open-Label Study 46
Glucocorticoid sparing effect of Janus Kinase inhibitors compared to biological Disease Modifying Anti-Rheumatic Drugs in rheumatoid arthritis, a single-center retrospective analysis 41
Secukinumab retention rate is greater in patients with psoriatic arthritis presenting with axial involvement 33
Efficacy and safety of digital nerve block for pain management during sharp debridement of digital ulcers in systemic sclerosis: A prospective observational study 30
Gender differences in psychological features and determinates of quality of life in axial spondyloarthritis and psoriatic arthritis: a cross-sectional study 28
Effects of tofacitinib on bone turnover markers and bone modulators in patients with rheumatoid arthritis 27
Four-year effectiveness, safety and drug retention rate of secukinumab in psoriatic arthritis: a real-life Italian multicenter cohort 24
Four-year real-world experience of secukinumab in a large Italian cohort of axial spondyloarthritis 22
Totale 6.551
Categoria #
all - tutte 25.322
article - articoli 23.072
book - libri 0
conference - conferenze 506
curatela - curatele 0
other - altro 340
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.404
Totale 50.644


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021332 0 0 14 43 68 51 9 40 28 5 47 27
2021/2022459 23 147 12 13 27 19 7 23 44 7 38 99
2022/2023998 70 107 84 177 54 244 11 68 122 17 33 11
2023/2024539 23 30 43 53 70 94 23 65 7 14 75 42
2024/20251.499 71 79 73 223 79 60 90 66 223 133 129 273
2025/2026811 306 256 249 0 0 0 0 0 0 0 0 0
Totale 6.551